Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape

Area of Science:

• Immunology
• Nanotechnology
• Molecular Biology

Background:

• Messenger RNA (mRNA) technology has emerged as a significant therapeutic and prophylactic modality.
• mRNA's potential spans various diseases, including cancer, rare diseases, and infectious diseases like COVID-19.
• Improving mRNA stability and delivery is crucial for successful therapeutic outcomes.

Purpose of the Study:

• To review diverse nanoplatforms used for mRNA delivery in preclinical and clinical settings.
• To discuss formulation, preparation, transfection efficiency, and administration routes of nanotech-based mRNA systems.
• To explore the market situation and future prospects of mRNA vaccines.

Main Methods:

• Review of existing literature on nanotechnology-based mRNA delivery systems.
• Analysis of various nanocarriers, including lipid nanoparticles, lipoplexes, polyplexes, and hybrid nanoparticles.
• Examination of formulation strategies, preparation processes, and transfection efficiencies.

Main Results:

• Nanotechnology platforms effectively protect mRNA from degradation and enhance endosomal escape.
• Diverse nanoplatforms are being explored and utilized in both preclinical and clinical stages.
• Key parameters like formulation, preparation, transfection efficiency, and administration routes are critical for efficacy.

Conclusions:

• Nanotechnology-based delivery systems are vital for advancing mRNA therapeutics.
• Further research and development in nanoplatforms will drive the clinical application of mRNA vaccines.
• The market for mRNA vaccines shows significant growth potential.